Press Coverage

Neurosurgeons identify malign tumors with Cellvizio optical biopsy

11 September 2015

A team of neurosurgeons in Germany has used the Cellvizio optical biopsy system to identify cancerous brain and spinal tumors in real time, suggesting that the technology could be used for immediate diagnosis in future operations to improve surgical outcomes and patient recovery.

Latest News

Mauna Kea Technologies Announces CE MDR Certification For Cellvizio® and Its Associated Probes

Mauna Kea Technologies Announces CE MDR Certification For Cellvizio® and Its Associated Probes

Mauna Kea Technologies Announces New Commercial Organization to Accelerate Growth Outside the United States

Mauna Kea Technologies Announces New Commercial Organization to Accelerate Growth Outside the United States

Mauna Kea Technologies announces Initiation of Coverage by Allinvest Securities 

Mauna Kea Technologies announces Initiation of Coverage by Allinvest Securities 

No results found.